IRIS
NIKOLIC, Dragana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.171
NA - Nord America 678
EU - Europa 467
SA - Sud America 298
AF - Africa 35
OC - Oceania 3
AN - Antartide 1
Totale 2.653
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 632
SG - Singapore 457
HK - Hong Kong 240
BR - Brasile 226
CN - Cina 171
IT - Italia 145
DE - Germania 104
VN - Vietnam 98
RU - Federazione Russa 58
FR - Francia 43
IN - India 36
ID - Indonesia 28
GB - Regno Unito 27
AR - Argentina 25
CA - Canada 23
BD - Bangladesh 20
IQ - Iraq 19
FI - Finlandia 17
MX - Messico 16
NL - Olanda 15
ZA - Sudafrica 13
ES - Italia 11
SA - Arabia Saudita 11
TR - Turchia 11
VE - Venezuela 11
EC - Ecuador 10
JP - Giappone 10
CO - Colombia 9
PH - Filippine 9
UZ - Uzbekistan 9
AT - Austria 7
NP - Nepal 7
PY - Paraguay 6
RS - Serbia 6
BE - Belgio 5
EG - Egitto 5
IL - Israele 5
PK - Pakistan 5
PL - Polonia 5
SE - Svezia 5
CL - Cile 4
JO - Giordania 4
KG - Kirghizistan 4
LT - Lituania 4
MA - Marocco 4
MY - Malesia 4
UA - Ucraina 4
UY - Uruguay 4
AU - Australia 3
HN - Honduras 3
TH - Thailandia 3
TN - Tunisia 3
BH - Bahrain 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
GR - Grecia 2
IR - Iran 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
QA - Qatar 2
TJ - Tagikistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
GD - Grenada 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MM - Myanmar 1
MN - Mongolia 1
NA - Namibia 1
NG - Nigeria 1
PE - Perù 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 2.653
Salva come PNG Salva come JPEG
Città #
Hong Kong 239
Singapore 148
Ashburn 110
Beijing 94
San Jose 57
Ho Chi Minh City 31
Wermelskirchen 28
Bari 26
Los Angeles 25
Council Bluffs 23
Dallas 23
Falkenstein 22
Hanoi 19
Lauterbourg 19
Chicago 18
São Paulo 18
Buffalo 17
Düsseldorf 17
Milan 17
Santa Clara 17
Rome 16
Jakarta 15
Munich 15
New York 15
Helsinki 13
Frankfurt am Main 11
Orem 10
Tashkent 9
Vancouver 9
Rio de Janeiro 8
Tokyo 8
Baghdad 7
Brooklyn 7
Chennai 7
Nuremberg 7
Tenafly 7
Amsterdam 6
Belgrade 6
London 6
Toronto 6
Boardman 5
Denver 5
Dhaka 5
Haiphong 5
Jeddah 5
Johannesburg 5
Mexico City 5
Palermo 5
Riyadh 5
Shanghai 5
Barquisimeto 4
Buenos Aires 4
Cairo 4
Caracas 4
Catania 4
Caxias do Sul 4
Charlotte 4
City of London 4
Goiânia 4
Kathmandu 4
North Bergen 4
Poplar 4
Vienna 4
Amman 3
Belo Horizonte 3
Benevento 3
Bishkek 3
Biên Hòa 3
Brasília 3
Brussels 3
Curitiba 3
Da Nang 3
Florianópolis 3
Fortaleza 3
Hortolândia 3
Medellín 3
Montevideo 3
Montreal 3
Mumbai 3
Ninh Bình 3
Osasco 3
Pagani 3
Quito 3
Ribeirão Preto 3
Roubaix 3
San Severo 3
Stockholm 3
Tampa 3
Turku 3
Warsaw 3
Zhengzhou 3
Addis Ababa 2
Altamura 2
Araraquara 2
Atlanta 2
Bangkok 2
Barra Mansa 2
Belford Roxo 2
Bogotá 2
Bologna 2
Totale 1.360
Salva come PNG Salva come JPEG
Nome #
An overview of statin-induced myopathy and perspectives for the future 151
Crithmum maritimum Extract Restores Lipid Homeostasis and Metabolic Profile of Liver Cancer Cells to a Normal Phenotype 107
A multicomponent personalized prevention program in the primary care setting: a randomized clinical trial in older people with noncommunicable chronic diseases (Primacare_P3 study) 96
Cellular Adaptation Takes Advantage of Atavistic Regression Programs during Carcinogenesis 91
Anti-inflammatory properties of an aldehydes-enriched fraction of grapefruit essential oil 78
Alcoholic liver cirrhosis, more than a simple hepatic disease - A brief review of the risk factors associated with alcohol abuse 74
The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes 66
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study 64
A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study 60
Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors 57
Dysfunctional mitochondrial bioenergetics sustains drug resistance in cancer cells 55
Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study 53
Daily Use of Extra Virgin Olive Oil with High Oleocanthal Concentration Reduced Body Weight, Waist Circumference, Alanine Transaminase, Inflammatory Cytokines and Hepatic Steatosis in Subjects with the Metabolic Syndrome: A 2-Month Intervention Study 53
Drug evaluation: The combination of fenofibrate and simvastatin for the treatment of dyslipidemia: When and for whom? 51
Microenvironmental stress drives tumor cell maladaptation and malignancy through regulation of mitochondrial and nuclear cytochrome c oxidase subunits 50
Preliminary results of CitraVes™ effects on low density lipoprotein cholesterol and waist circumference in healthy subjects after 12 weeks: A pilot open-label study 50
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 50
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 49
An evaluation of RVX-208 for the treatment of atherosclerosis 48
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect 47
Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study 45
Liraglutide Increases Serum Levels of MicroRNA-27b, -130a and -210 in Patients with Type 2 Diabetes Mellitus: A Novel Epigenetic Effect 45
Anti-cytokine therapy for prevention of atherosclerosis 44
A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? 44
Weight loss programmes using low carbohydrate diets to control the cardiovascular risk in adolescents (Review) 43
Effects of Aging and Diet on Cardioprotection and Cardiometabolic Risk Markers 43
Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children 41
Can the effects of gender, menopause and ageing on lipid levels be differentiated? 39
Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia 34
Adipokines and lipoproteins: Modulation by antihyperglycemic and hypolipidemic agents 34
Should low high-density lipoprotein cholesterol (HDL-C) be treated? 32
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 32
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study 31
Effects of chitosan on plasma lipids and lipoproteins: A 4-month prospective pilot study 29
Management of Statin Intolerance in 2018: Still More Questions Than Answers 29
Gut Microbiota, Obesity and Bariatric Surgery: Current Knowledge and Future Perspectives 29
Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality 27
Natural approaches in metabolic syndrome management 24
The Role of Nutraceuticals in Statin Intolerant Patients 24
Nutraceuticals in Lipid-Lowering Treatment: A Narrative Review on the Role of Chitosan 24
LDL and HDL subfractions, dysfunctional HDL: treatment options 24
Uric acid metabolism in pre-hypertension and the metabolic syndrome 23
Intensive LDL-cholesterol lowering therapy and neurocognitive function 23
Lifestyle recommendations for the prevention and management of metabolic syndrome: An international panel recommendation 22
Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis 22
Periodontitis, blood lipids and lipoproteins 21
Resistin: An inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome 20
Exosomal Heat Shock Proteins as New Players in Tumour Cell-to-Cell Communication 20
The role of fibrate treatment in dyslipidemia: an overview 20
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms 19
Nutraceuticals as lipid-lowering treatment in pregnancy and their effects on the metabolic syndrome 19
Nutraceuticals as new therapeutic strategies for health and wellbeing 19
Small, dense LDL: an update 19
The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: Current knowledge and future perspective 19
Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials 18
Psoriasis and acute coronary syndrome risk 17
Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease 17
Peroxisome proliferator-activated receptors and atherosclerosis 17
The extra-glycemic effects of liraglutide: Focus on cardiometabolic markers 17
Oxidative stress and the role of antioxidative treatment in diabetes mellitus 17
Involvement of the ADAM 12 in thrombin-induced rat's VSMCs proliferation 17
Subfractions and subpopulations of HDL: An update 17
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: An 8-month prospective pilot study 17
Incretins, pregnancy, and gestational diabetes 16
Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: A prospective pilot study 16
Novel anti-obesity drugs and plasma lipids 16
EXOSOMES: PROMISING NON-INVASIVE DIAGNOSTIC AND THERAPEUTIC TOOLS 16
Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches 16
Statin intolerance - An attempt at a unified definition. Position paper from an International Lipid Expert Panel 15
Gestational diabetes and the metabolic syndrome: can obesity and small, dense low density lipoproteins be key mediators of this association? 15
The effect of bergamot on dyslipidemia 15
Regulation of inducible Nitric Oxide synthase (iNOS) and its potential role in insulin resistance, diabetes and heart failure 15
Serum lipoproteins are not associated with the severity of asthma 15
Emerging approaches for the treatment of hypertriglyceridemia 14
Nutraceuticals as an important part of combination therapy in dyslipidaemia 14
ETC-1002: A future option for lipid disorders? 14
IMPROVE-IT: What have we learned? 14
Serum low density lipoprotein subclasses in asthma 14
Statin intolerance-an attempt at a unified definition. Position paper from an International Lipid Expert Panel 13
The dissociation of the Hsp60/pro-Caspase-3 complex by bis(pyridyl)oxadiazole copper complex (CubipyOXA) leads to cell death in NCI-H292 cancer cells 13
PPAR agonists, atherogenic dyslipidemia and cardiovascular risk 12
Statin treatment in the elderly: how much do we know? 12
Incretin-based therapies, glucometabolic health and endovascular inflammation 12
Statins and new-onset diabetes 12
GLP-1 receptor agonists, carotid atherosclerosis and retinopathy 11
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg) 4
Totale 2.801
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.741
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202393 0 0 0 0 0 0 0 0 0 0 90 3
2023/2024114 0 0 1 80 0 3 0 2 7 3 5 13
2024/2025802 15 3 38 18 33 43 56 75 44 30 127 320
2025/20261.792 341 134 144 237 203 99 179 52 205 198 0 0
Totale 2.801